21/07/2025 06:00
|
Medical, Health & Aged Care
NEWS RELEASE
For consumer media only
First treatment option SKYCLARYS™ (omaveloxolone) for Australian’s diagnosed with ‘neurogenerative disease’ Friedreich ataxia[1]
The TGA has registered...